Skip to content

Advertisement

BMC Neurology

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

A case of late-onset, thymoma-associated myasthenia gravis with ryanodine receptor and titin antibodies and concomitant granulomatous myositis

  • M. I. Stefanou1Email author,
  • L. Komorowski2,
  • S. Kade2,
  • A. Bornemann3,
  • U. Ziemann1 and
  • M. Synofzik4, 5
BMC NeurologyBMC series – open, inclusive and trusted201616:172

https://doi.org/10.1186/s12883-016-0697-x

Received: 2 June 2016

Accepted: 7 September 2016

Published: 13 September 2016

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
2 Jun 2016 Submitted Original manuscript
Author responded Author comments
Reviewed Reviewer Report
Resubmission - Version 2
Submitted Manuscript version 2
Author responded Author comments
Resubmission - Version 3
Submitted Manuscript version 3
Publishing
7 Sep 2016 Editorially accepted
13 Sep 2016 Article published 10.1186/s12883-016-0697-x

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Department of Neurovascular Diseases, Hertie Institute for Clinical Brain Research & Center for Neurology, Tuebingen, Germany
(2)
Institute for Experimental Immunology, Affiliated to Euroimmun AG, Luebeck, Germany
(3)
Department of Neuropathology, University of Tuebingen, Tuebingen, Germany
(4)
Department of Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research & Center for Neurology, Tuebingen, Germany
(5)
Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE), Tuebingen, Germany

Advertisement